Related Experiment Videos
High-yield retroviral production using a temperature-modulated two-stage operation.
Young Jik Kwon1, Ching-An Peng
1Department of Chemical Engineering, University of Southern California, Los Angeles, California 90089,USA.
Biotechnology and Bioengineering
|April 2, 2005
Summary
This study introduces a novel method to increase infectious retroviral vector production. Circulating culture medium through an ice-cold reservoir significantly boosts retroviral titers and yield for clinical applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Virology
Background:
- High-titer retroviral supernatants are crucial for clinical trials.
- Retroviral vectors have low concentration and short half-lives, limiting infectious yield.
- Current production methods face challenges in achieving sufficient quantities of infectious retroviral vectors.
Purpose of the Study:
- To develop an optimized method for mass production of high-titer retroviral supernatants.
- To enhance the yield of infectious retroviral vectors compared to static culture methods.
- To investigate the effect of temperature on retroviral stability and production.
Main Methods:
- A system was developed to circulate ecotropic retrovirus-producing cell culture medium through a reservoir.
- The reservoir was configured with either an incubator (37°C) or an ice-bath stage (cold).
- Retroviral titers were measured from static and circulating cultures under different temperature conditions.
Main Results:
- Circulating supernatant through an ice-cold reservoir increased retroviral titers for up to a week.
- Static production or circulation through a 37°C reservoir resulted in titers plateauing after 3 days.
- Five-day production yielded 10 times more infectious retroviruses using the cold reservoir method compared to static cultures.
- Low temperatures reduced transduction inhibitors and slowed retroviral decay.
Conclusions:
- A two-stage operation involving circulation through a cold reservoir significantly enhances retroviral vector production.
- This method overcomes limitations of low concentration and short half-lives of retroviral vectors.
- The developed system is adaptable for large-scale bioreactors for efficient mass production of high-titer retroviral supernatants.